Nicolas Arlicot, Ph.D. - Publications

Affiliations: 
2009 Universite de Tours 

42/59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Vala C, Mothes C, Chicheri G, Magadur P, Viot G, Deloye JB, Maia S, Bouvet Y, Dupont AC, Arlicot N, Guilloteau D, Emond P, Vercouillie J. Fully automated radiosynthesis of [F]LBT999 on TRACERlab FX and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain. Ejnmmi Radiopharmacy and Chemistry. 5: 26. PMID 33196944 DOI: 10.1186/s41181-020-00105-w  0.536
2020 Ribeiro MJ, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier JP, Maia S, Deloye JB, Emond P, Guilloteau D. Usefulness of PET With [F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment. Frontiers in Neurology. 11: 754. PMID 32973645 DOI: 10.3389/fneur.2020.00754  0.564
2020 Ribeiro M, Vercouillie J, Arlicot N, Tauber C, Gissot V, Mondon K, Barantin L, Cottier J, Maia S, Deloye J, Emond P, Guilloteau D. Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment Frontiers in Neurology. 11. DOI: 10.3389/Fneur.2020.00754  0.604
2019 Beaurain M, Salabert AS, Ribeiro MJ, Arlicot N, Damier P, Le Jeune F, Demonet JF, Payoux P. Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience. Frontiers in Medicine. 6: 268. PMID 31828073 DOI: 10.3389/Fmed.2019.00268  0.429
2019 Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, Payoux P, Vellas B, El-Hage W, Tavernier E, Camus V, et al. Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort. Neurobiology of Aging. 84: 61-69. PMID 31514054 DOI: 10.1016/J.Neurobiolaging.2019.08.008  0.315
2019 Arlicot N, Vercouillie J, Malherbe C, Bidault R, Gissot V, Maia S, Barantin L, Cottier JP, Deloye JB, Guilloteau D, Ribeiro MJ. PET imaging of Dopamine Transporter with [18F]LBT-999: initial evaluation in healthy volunteers. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 31496203 DOI: 10.23736/S1824-4785.19.03175-3  0.563
2019 Bodet-Milin C, Bailly C, Touchefeu Y, Frampas E, Bourgeois M, Rauscher A, Lacoeuille F, Drui D, Arlicot N, Goldenberg DM, Faivre-Chauvet A, Barbet J, Rousseau C, Kraeber-Bodéré F. Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches. Frontiers in Medicine. 6: 124. PMID 31214593 DOI: 10.3389/Fmed.2019.00124  0.378
2019 Chalon S, Vercouillie J, Payoux P, Deloye JB, Malherbe C, Le Jeune F, Arlicot N, Salabert AS, Guilloteau D, Emond P, Ribeiro MJ. The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use. Frontiers in Medicine. 6: 90. PMID 31131278 DOI: 10.3389/Fmed.2019.00090  0.611
2019 Elie J, Vercouillie J, Arlicot N, Lemaire L, Bidault R, Bodard S, Hosselet C, Deloye JB, Chalon S, Emond P, Guilloteau D, Buron F, Routier S. Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [F] PET tracer. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 1-7. PMID 30362376 DOI: 10.1080/14756366.2018.1501043  0.562
2019 Malherbe C, Bidault R, Netter C, Guilloteau D, Vercouillie J, Arlicot N. Development of a Fast and Facile Analytical Approach to Quantify Radiometabolites in Human Plasma Samples Using Ultra High Performance Liquid Chromatography American Journal of Analytical Chemistry. 10: 185-201. DOI: 10.4236/Ajac.2019.105016  0.535
2018 Dupont AC, Largeau B, Guilloteau D, Santiago Ribeiro MJ, Arlicot N. The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases. Contrast Media & Molecular Imaging. 2018: 7043578. PMID 29887768 DOI: 10.1155/2018/7043578  0.611
2018 Ribeiro MS, Vercouillie J, Gissot V, Maia S, Barantin L, Peltier Y, Cottier J, Deloye J, Arlicot N, Guilloteau D. Le 18F-LBT-999, le nouveau traceur TEP du DAT ? MéDecine NucléAire. 42: 137-138. DOI: 10.1016/J.Mednuc.2018.03.017  0.555
2017 Largeau B, Dupont AC, Guilloteau D, Santiago-Ribeiro MJ, Arlicot N. TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases? Contrast Media & Molecular Imaging. 2017: 6592139. PMID 29114179 DOI: 10.1155/2017/6592139  0.618
2017 Malherbe C, Dupont AC, Maia S, Venel Y, Erra B, Santiago-Ribeiro MJ, Arlicot N. Estimation of the added value of 99mTc-HMPAO labelled white blood cells scintigraphy for the diagnosis of infectious foci. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 28478665 DOI: 10.23736/S1824-4785.17.02964-8  0.365
2017 Tronel C, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Dupont AC, Arlicot N. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations. International Journal of Molecular Sciences. 18. PMID 28398245 DOI: 10.3390/Ijms18040802  0.611
2017 Dupont AC, Largeau B, Santiago Ribeiro MJ, Guilloteau D, Tronel C, Arlicot N. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. International Journal of Molecular Sciences. 18. PMID 28387722 DOI: 10.3390/Ijms18040785  0.634
2017 Dupont A, Malherbe C, Berry O, Venel Y, Santiago Ribeiro M, Arlicot N, Maia S. Impact médico-économique de la surveillance des prescriptions de TEP-18F-FDG MéDecine NucléAire. 41: 185. DOI: 10.1016/J.Mednuc.2017.02.126  0.364
2017 Malherbe C, Ligonie A, Dupont A, Courtehoux M, Venel Y, Santiago Ribeiro M, Arlicot N, Maia S. Intérêt diagnostique de la scintigraphie des récepteurs à la somatostatine à l’111Indium-pentetréotide (Octréoscan ® ) : étude rétrospective au CHRU de Tours MéDecine NucléAire. 41: 184. DOI: 10.1016/J.Mednuc.2017.02.124  0.305
2017 Santiago Ribeiro M, Vercouillie J, Maia S, Gissot V, Bonnet Brilhault F, Guilloteau D, Arlicot N. Cinétique cérébrale du [18F]-FPEB, radioligand spécifique du mGluR5, chez le volontaire sain MéDecine NucléAire. 41: 168-169. DOI: 10.1016/J.Mednuc.2017.02.080  0.546
2017 Dupont A-, Ribeiro M-S, Guilloteau D, Arlicot N. β-amyloid PET neuroimaging: A review of radiopharmaceutical development Medecine Nucleaire-Imagerie Fonctionnelle Et Metabolique. 41: 27-35. DOI: 10.1016/J.Mednuc.2016.12.002  0.368
2016 Barbet J, Arlicot N, Gaugler MH, Chérel M, Guilloteau D, Kraeber-Bodéré F. Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology. Frontiers in Medicine. 3: 74. PMID 28123998 DOI: 10.3389/Fmed.2016.00074  0.541
2016 Dupont AC, Guilloteau D, Kassiou M, Ribeiro MJ, Vercouillie J, Katsifis A, Arlicot N. Radiopharmaceuticals for PET imaging of neuroinflammation Medecine Nucleaire. 40: 72-81. DOI: 10.1016/J.Mednuc.2016.01.001  0.61
2015 Dupont A, Guilloteau D, Ben-Azzouna R, Bidault R, Algalarrondo V, Slama M, Arlicot N, Le Guludec D. [18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study Orphanet Journal of Rare Diseases. 10. DOI: 10.1186/1750-1172-10-S1-P38  0.55
2015 Santiago-Ribeiro M, Vercouillie J, Cottier J, Debiais S, Bonnaud I, Annan M, Maia S, Kassiou M, Arlicot N, Guilloteau D. Évaluation en TEP de l’activation microgliale après un accident vasculaire cérébral MéDecine NucléAire. 39: 210. DOI: 10.1016/J.Mednuc.2015.03.015  0.337
2014 Arlicot N, Tronel C, Bodard S, Garreau L, de la Crompe B, Vandevelde I, Guilloteau D, Antier D, Chalon S. Translocator Protein (18 kDa) Mapping with [(125)I]-CLINDE in the Quinolinic Acid Rat Model of Excitotoxicity: A Longitudinal Comparison with Microglial Activation, Astrogliosis, and Neuronal Death. Molecular Imaging. 13: 7290201300075. PMID 28650286 DOI: 10.2310/7290.2013.00075  0.505
2014 Ribeiro MJ, Vercouillie J, Debiais S, Cottier JP, Bonnaud I, Camus V, Banister S, Kassiou M, Arlicot N, Guilloteau D. Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period? Ejnmmi Research. 4: 28. PMID 25006546 DOI: 10.1186/S13550-014-0028-4  0.578
2014 Arlicot N, Tronel C, Bodard S, Garreau L, de la Crompe B, Vandevelde I, Guilloteau D, Antier D, Chalon S. Translocator protein (18 kDa) mapping with [125I]-CLINDE in the quinolinic acid rat model of excitotoxicity: a longitudinal comparison with microglial activation, astrogliosis, and neuronal death. Molecular Imaging. 13: 4-11. PMID 24622813 DOI: 10.2310/7290.2013.00075  0.551
2014 Hommet C, Mondon K, Camus V, Ribeiro MJ, Beaufils E, Arlicot N, Corcia P, Paccalin M, Minier F, Gosselin T, Page G, Guilloteau D, Chalon S. Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging. Dementia and Geriatric Cognitive Disorders. 37: 1-18. PMID 24107621 DOI: 10.1159/000354363  0.556
2013 Martins AF, Morfin JF, Kubí?ková A, Kubí?ek V, Buron F, Suzenet F, Salerno M, Lazar AN, Duyckaerts C, Arlicot N, Guilloteau D, Geraldes CF, Tóth E. PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques. Acs Medicinal Chemistry Letters. 4: 436-40. PMID 24900692 DOI: 10.1021/Ml400042W  0.54
2013 Petitcollin A, Maia S, Guilloteau D, Dupuis S, Arlicot N. Développement d’une méthode rapide de chromatographie sur couche mince pour le contrôle qualité du 99mTc-HMPAO en routine MéDecine NucléAire. 37: 171. DOI: 10.1016/J.Mednuc.2013.03.137  0.522
2013 Santiago-Ribeiro M, Vercouillie J, Corcia P, Arlicot N, Erra B, Maia S, Bonnaud I, Debiais S, Kassiou M, Guilloteau D. Distribution cérébrale du 18F-DPA-714 et neuro-inflammation aiguë et chronique MéDecine NucléAire. 37: 141-142. DOI: 10.1016/J.Mednuc.2013.03.025  0.551
2013 Erra B, Vercouillie J, Corcia P, Maïa S, Arlicot N, Baulieu J, Guilloteau D, Santiago Ribeiro M. Distribution physiologique cérébrale et corps entier du 18F-DPA-714 en TEP/TDM MéDecine NucléAire. 37: 44-51. DOI: 10.1016/J.Mednuc.2013.01.004  0.572
2012 Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. Plos One. 7: e52941. PMID 23300829 DOI: 10.1371/Journal.Pone.0052941  0.588
2012 Maia S, Arlicot N, Vierron E, Bodard S, Vergote J, Guilloteau D, Chalon S. Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Synapse (New York, N.Y.). 66: 573-83. PMID 22337286 DOI: 10.1002/Syn.21543  0.543
2012 Arlicot N, Vercouillie J, Ribeiro MJ, Tauber C, Venel Y, Baulieu JL, Maia S, Corcia P, Stabin MG, Reynolds A, Kassiou M, Guilloteau D. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nuclear Medicine and Biology. 39: 570-8. PMID 22172392 DOI: 10.1016/J.Nucmedbio.2011.10.012  0.623
2012 Arlicot N, Chalon S, Vercouillie J, Bodard S, Serrière S, Ribeiro M, Baulieu J, Stabin M, Kassiou M, Guilloteau D. Estimation de la dosimétrie chez l’homme du [18F]Dpa-714, un radiopharmaceutique pour l’imagerie TEP de la neuroinflammation MéDecine NucléAire. 36: 169. DOI: 10.1016/J.Mednuc.2012.02.040  0.338
2012 Santiago-Ribeiro M, Vercouille J, Tauber C, Venel Y, Baulieu J, Maia S, Arlicot N, Corcia P, Kassiou M, Guilloteau D. Cinétique cérébrale du [18F]DPA-714 en tomographie par émission de positons chez le volontaire sain MéDecine NucléAire. 36: 169. DOI: 10.1016/J.Mednuc.2012.02.039  0.583
2012 Duval S, Siñeriz F, Arlicot N, Barbier-Chassefire V, Vercouillie J, Delbé J, Papy-Garcia D, Guilloteau D, Barritault D. Development of radiotracers for the molecular imaging of tumor matrix microenvironment (HIMIMT) | Développement de radiotraceurs pour l'imagerie moléculaire du microenvironnement matriciel tumoral (HIMIMT) Irbm. 33: 86-91. DOI: 10.1016/J.Irbm.2012.01.006  0.5
2010 Arlicot N, Petit E, Katsifis A, Toutain J, Divoux D, Bodard S, Roussel S, Guilloteau D, Bernaudin M, Chalon S. Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. European Journal of Nuclear Medicine and Molecular Imaging. 37: 2371-80. PMID 20814674 DOI: 10.1007/S00259-010-1598-7  0.567
2010 Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, Chalon S, Garreau L, Kung HF, Lantier F, Vergote J. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 576-82. PMID 20376566 DOI: 10.1007/S11307-010-0321-1  0.568
2008 Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Kousignian I, Bodard S, Guilloteau D, Chalon S. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. European Journal of Nuclear Medicine and Molecular Imaging. 35: 2203-11. PMID 18536913 DOI: 10.1007/S00259-008-0834-X  0.726
2008 Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S, Kousignian I, Bodard S, Guilloteau D, Chalon S. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-008-0834-x) European Journal of Nuclear Medicine and Molecular Imaging. 35: 2341. DOI: 10.1007/s00259-008-0882-2  0.734
Low-probability matches (unlikely to be authored by this person)
2013 Tronel C, Rochefort GY, Arlicot N, Bodard S, Chalon S, Antier D. Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model. Oxidative Medicine and Cellular Longevity. 2013: 264935. PMID 23533686 DOI: 10.1155/2013/264935  0.289
2017 Faivre-Chauvet A, Guillet B, Lacoeuille F, Mazere J, Arlicot N. Points clés du circuit du médicament radiopharmaceutique au regard des spécificités liées à la radiothérapie interne et à la recherche biomédicale MéDecine NucléAire. 41: 239-240. DOI: 10.1016/J.Mednuc.2017.02.014  0.284
2018 Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, et al. Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study). Frontiers in Psychiatry. 9: 326. PMID 30087626 DOI: 10.3389/Fpsyt.2018.00326  0.283
2022 Gouilly D, Saint-Aubert L, Ribeiro MJ, Salabert AS, Tauber C, Péran P, Arlicot N, Pariente J, Payoux P. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update. The European Journal of Neuroscience. PMID 35083791 DOI: 10.1111/ejn.15613  0.254
2018 Lacoeuille F, Arlicot N, Faivre-Chauvet A. Targeted alpha and beta radiotherapy: An overview of radiopharmaceutical and clinical aspects Medecine Nucleaire-Imagerie Fonctionnelle Et Metabolique. 42: 32-44. DOI: 10.1016/J.Mednuc.2017.12.002  0.252
2021 Dupont AC, Serrière S, Barantin L, Vercouillie J, Tauber C, Gissot V, Bodard S, Chicheri G, Chalon S, Bonnet-Brilhault PF, Santiago-Ribeiro PM, Arlicot N. Study of influence of the glutamatergic concentration of [F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers. Translational Psychiatry. 11: 66. PMID 33473111 DOI: 10.1038/s41398-020-01152-2  0.252
2019 Bailly C, Carlier T, Touzeau C, Arlicot N, Kraeber-Bodéré F, Le Gouill S, Bodet-Milin C. Interest of FDG-PET in the Management of Mantle Cell Lymphoma. Frontiers in Medicine. 6: 70. PMID 31024918 DOI: 10.3389/fmed.2019.00070  0.246
2021 Dagallier C, Avry F, Touchefeu Y, Buron F, Routier S, Chérel M, Arlicot N. Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of and Preclinical Imaging Studies. Frontiers in Medicine. 8: 675209. PMID 34169083 DOI: 10.3389/fmed.2021.675209  0.234
2023 Dupont AC, Arlicot N, Vercouillie J, Serrière S, Maia S, Bonnet-Brilhault F, Santiago-Ribeiro MJ. Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks. Pharmaceuticals (Basel, Switzerland). 16. PMID 37631042 DOI: 10.3390/ph16081127  0.228
2021 Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Delrieu J, Lebouvier T, Robert G, David R, Bulteau S, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MJ, et al. Benzodiazepine use and neuroimaging markers of Alzheimer's disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34893757 DOI: 10.1038/s41386-021-01246-5  0.226
2012 Farooq RK, Isingrini E, Tanti A, Le Guisquet AM, Arlicot N, Minier F, Leman S, Chalon S, Belzung C, Camus V. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? Behavioural Brain Research. 231: 130-7. PMID 22465167 DOI: 10.1016/J.Bbr.2012.03.020  0.226
2007 Arlicot N, Pourrat X, Bourgoin-Hérard H, Grassin J, Antier D. Are antibiotic drugs well prescribed in case of renal insufficiency? A retrospective study. Renal Failure. 29: 1055-8. PMID 18067057 DOI: 10.1080/08860220701643617  0.205
2023 Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Campion JY, Michels PE, Delrieu J, Lebouvier T, Balageas AC, Surget A, Belzung C, Arlicot N, Ribeiro MS, Gissot V, et al. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 37973486 DOI: 10.1016/j.jagp.2023.10.002  0.183
2007 Arlicot N, Rochefort GY, Schlecht D, Lamoureux F, Marchand S, Antier D. Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers. Pediatrics. 120: 1255-9. PMID 18055674 DOI: 10.1542/Peds.2007-0630  0.18
2022 Galineau L, Arlicot N, Dupont AC, Briend F, Houy-Durand E, Tauber C, Gomot M, Gissot V, Barantin L, Lefevre A, Vercouillie J, Roussel C, Roux S, Nadal L, Mavel S, et al. Glutamatergic synapse in autism: a complex story for a complex disorder. Molecular Psychiatry. PMID 36434055 DOI: 10.1038/s41380-022-01860-9  0.133
2023 Desmidt T, Dujardin PA, Andersson F, Brizard B, Réméniéras JP, Gissot V, Arlicot N, Barantin L, Espitalier F, Belzung C, Tanti A, Robert G, Bulteau S, Gallet Q, Kazour F, et al. Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study. Molecular Psychiatry. PMID 37592013 DOI: 10.1038/s41380-023-02217-6  0.104
2021 Desmidt T, Gissot V, Dujardin PA, Andersson F, Barantin L, Brizard B, Arlicot N, Réméniéras JP, Espitalier F, El-Hage W, Camus V. A Case of Sustained Antidepressant Effects and Large Changes in the Brain With a Single Brief Exposure to Nitrous Oxide. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 33612348 DOI: 10.1016/j.jagp.2021.01.138  0.076
Hide low-probability matches.